In endometrial cancer, PR status is also an important prognostic marker. PR-positive status is generally associated with a better prognosis and a lower risk of cancer recurrence. Hormone therapy, including progestins, may be used to treat PR-positive endometrial cancer, particularly in patients who wish to preserve fertility or in cases where surgery is not an option.
